Your browser does not support iframes.
2016 Disclosure – North America
Ethical Conduct & Integrity— Teva personnel are expected to maintain thehighest standards of integrity in their relationswith patient organizations.
Transparency— Teva will be open and transparent regardingrelationships with patient organizations.— Teva will publicly disclose financial support andsignificant non-financial support provided topatient organizations. Further, patientorganizations may publish Teva’s support oftheir programs as they deem appropriate.— Teva’s global policy on patient organizationengagement will be made available to patientgroups.
Mutual Benefit— Teva’s support of patient organizations isfocused on improving the welfare of patients,families and caregivers. Any activity undertakenwith patient organizations must clearlydemonstrate benefit to the patients whoseinterests the patient groups represents— Successful partnerships between patientorganizations and Teva must provide mutualbenefit to both organizations.
— Therefore, Teva will seek to build mutuallybeneficial relationships with patientorganizations in areas where there is alignmentaround objectives and priorities.
Independence— A patient organization in partnership with Tevamust not have its independence compromised,nor should it be perceived to be compromised,and patient organizations retain the right topublicly object to the positions of the company.
Compliance— Every interaction company personnel and itsrepresentatives have with patient organizationswill comply with all government rules,regulations and guidelines, as well as with allapplicable Teva policies.
Non-Promotion— Teva must not use interactions and relationshipswith patient organizations to promote itsproducts or increase commercial awarenessof its products, except in countries that allowDirect to Consumer Advertising, and only whendone in compliance with all applicable laws andTeva policies governing product promotion